Zeb Jamrozik

Associate Professor Zeb Jamrozik serves as Associate Professor of Clinical Bioethics in the Department of Infectious Diseases within the Faculty of Medicine, Dentistry and Health Sciences at the University of Melbourne. He is a qualified internal medicine physician and Fellow of the Royal Australasian College of Physicians (FRACP). Jamrozik holds an MBBS from the University of Western Australia, obtained in 2008, and a PhD in Bioethics from Monash University. His academic career includes previous roles as a Research Fellow at the Monash Bioethics Centre, where he also served as Research Lead for Infectious Disease Ethics and co-editor-in-chief of the Monash Bioethics Review. Additionally, he has been affiliated with the Royal Melbourne Hospital Department of Medicine.

Jamrozik's research specializes in the ethics of infectious diseases, including controlled human infection studies, antibiotic resistance, vaccine policies, and public health interventions during pandemics. His work addresses ethical issues in COVID-19 human challenge studies, asymptomatic infections, and proportionality in public health measures. He has co-edited key books such as 'Ethics and Drug Resistance: Collective Responsibility for Global Public Health' (2020) and contributed to 'Human Challenge Studies in Endemic Settings: Ethical and Regulatory Issues' (2021). Notable publications include 'The unintended consequences of COVID-19 vaccine policy: why mandates, passports and restrictions may cause more harm than good' (BMJ Global Health, 2022, 420 citations), 'COVID-19 human challenge studies: ethical issues' (The Lancet Infectious Diseases, 2020, 168 citations), 'No jab, no job? Ethical issues in mandatory COVID-19 vaccination of healthcare personnel' (BMJ Global Health, 2021, 125 citations), and 'Key criteria for the ethical acceptability of COVID-19 human challenge studies: Report of a WHO Working Group' (Vaccine, 2021, 76 citations). His scholarship has significantly influenced debates on ethical policymaking in global health and infectious disease control.